Phenotypic and genotypic diversity of yeast isolated from cancer patients and their environment and their antifungal sensitivity pattern

##plugins.themes.bootstrap3.article.sidebar##

PDF
DOI https://doi.org/10.13057/biodiv/d240761
Issue
Vol. 24 No. 7 (2023)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

##plugins.themes.bootstrap3.article.main##

ZAHRAA DAWOOD GATEA AL-DARRAJI ♥
Department of Biology, College of Science, University of Basrah. Basrah, Iraq
MOHANAD KHALAF MOHAMMED-AMEEN
Department of Biology, College of Science, University of Basrah. Basrah, Iraq

Abstract

Abstract. Al-Darraji ZDG, Mohammed-Ameen MKM. 2023. Phenotypic and genotypic diversity of yeast isolated from cancer patients and their environment and their antifungal sensitivity pattern. Biodiversitas 24: 4166-4174. This study aimed to investigate yeast diversity and their antifungal susceptibility patterns in 853 samples collected from cancer patients, their apparently healthy companions, their beds, their tables, and indoor hospital air. The samples were cultured and identified using classical phenotypic characteristics and a molecular method utilizing amplification of ITS conservative regions of rRNA. The sum of phenotyping and genotyping identification revealed that 102 yeast isolates included 6 genera and 14 species. Candida sp. was the most dominant genera (84.31%), followed by Naganishia sp. (10.78%). Candida albicans (24.50%) and C. krusei (16.66%) were the most prevalent yeast species. Fluconazole, caspofungin, and voriconazole exhibited potent antifungal activities against the most yeast species with low minimum inhibitory concentration (MIC) values compared with high MIC (64 µg/mL) values against Meyerozyma guilliermondi, Naganishia difflunes, and C. tropicalis. To conclude, the antifungal activity was isolate- and species-specific and the higher antifungal concentrations led to a more-rapid expression of activity. The high isolation rate of yeasts from beds and tables, advocated the use of various monitoring systems to ensure thorough cleaning and consistent disinfection of surfaces around patients and health care providers. The study findings showed that the molecular method was superior to the phenotyping technique in identifying yeast isolates. While similar research has been performed in different locations, the current project represents a unique milestone for this particular institution, and offers an opportunity to advance research in this area.

##plugins.themes.bootstrap3.article.details##

References
REFERENCES
Abeed F K, Alrubayae I M. 2022. Evaluation of virulence factors of clinical yeast isolates from nosocomial fungal infections with the determination of their antifungal susceptibility profile. Iranian Journal of Ichthyology, 9, 61–68. Retrieved from https://ijichthyol.org/index.php/iji/article/view/764
Abu-Mejdad N M, Al-Badran A I, Al-Saadoon A H. 2019. A new record of interesting basidiomycetous yeasts from soil in Basrah province/Iraq. Basrah Journal of Science. Vol. 37 (3): 307- 334. DOI: 10.29072/basjs.201902012
Al-akeel RA, El-kershTA, Al-SheikhYA, and AlAhmadey Z Z. 2013. Prevalence and comparison for detection methods of Candida species in vaginal specimens from pregnant and non-pregnant Saudi women. Afri. J. of Microbi. R. 7(1): pp. 56-65. DOI: 10.5897/AJMR12.1979.
Al-laaeiby A I E, Al-Mousawi, A A, Alrubayae I M N, Al-Saadoon A and Almayahi M. 2020. "Innate pathogenic traits in oral yeasts," Karbala International Journal of Modern Science: Vol. 6: Iss. 4, Article 5. Available at: https://DOI: org/10.33640/2405-609X.1984
Alrubayae I M N, Al-laaeiby A, Minati M H, ALibraheem S A H. 2020. Determination of Genetic RelationshipsandPathogenicity of Oral Candidiasis Etiological AgentsinPediatric Malignant Patients in BasrahProvince, Iraq. Sys Rev Pharm; 11(12): 180-188
Aslani N, Janbabaei G, Abastabar M et al. 2018. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis 18, 24. https://DOI:org/10.1186/s12879-017-2916-5
Badiee P, Alborzi A. 2011. Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study. Iran J Microbiol. Dec; 3(4):183-8. PMID: 22530086; PMCID: PMC3330181.
Bayraktar S, Duran N, Duran GG, Eryilmaz N, Aslan H, Önlen C, Özer B. 2017. Identification of medically important Candida species by polymerase chain reaction-restriction fragment length polymorphism analysis of the rDNA ITS1 and ITS2 regions. Indian J Med Microbiol. Oct-Dec; 35(4):535-542. DOI: 10.4103/ijmm.IJMM_17_102. PMID: 29405146.
Berkow EL, Lockhart SR, Ostrosky-Zeichner L. 2020. Antifungal Susceptibility Testing: Current Approaches. Clin Microbiol Rev. Apr 29; 33(3):e00069-19. DOI: 10.1128/CMR.00069-19. PMID: 32349998; PMCID: PMC7194854..
Bijlani S, Parker C, Singh NK, Sierra MA, Foox J, Wang CCC, Mason CE, Venkateswaran K. 2022. Genomic Characterization of the Titan-like Cell Producing Naganishia tulchinskyi, the First Novel Eukaryote Isolated from the International Space Station. J Fungi (Basel). Feb 8; 8(2):165. DOI: 10.3390/jof8020165. PMID: 35205919; PMCID: PMC8875396.
Bitew A, Abebaw Y. 2018. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.BMC Women’s Health. 18(1).DOI:10.1186/s12905-018-0607-z.
Bongomin, F, Gago S, Oladele RO, Denning DW. 2017. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J. Fungi, 3, 57. https://DOI:org/10.3390/jof3040057.
Borman A M, Muller J, Quantick J W, Szekely A, Patterson Z, Palmer M D, Fraser M, Johnson E M. 2020. MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method, Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1194–1205, https://DOI:org/10.1093/jac/dkz568
Böttcher B, Pöllath C, Staib P, Hube B, Brunke S. 2016. Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation. Front Microbiol.; 27;7:1697. DOI: 10.3389/fmicb.2016.01697. PMID: 27833594; PMCID: PMC5081361.
Centers for Disease Control and Prevention/Healthcare Infection Control Advisory Committee (HICPAC) Guidelines for environmental infection control in healthcare facilities environ-mental surfaces, E.VI. B.2. and E.I.E.3. Atlanta [GA]: Centers for Disease Control and Prevention. 2003
Clinical and Laboratory Standards Institute. 2017. Performance standards for antifungal susceptibility testing of yeasts, 1st ed CLSI supplement M60 Clinical and Laboratory Standards Institute, Wayne PA.
Deorukhkar S C, Saini S, and Jadhav P A . 2012. Evaluate different media for germ tube production of C. albicans and C. dubliniensis . IJBAR., 3(9) : 704-707. DOI: 10.7439/ijbar.v3i9.732
Erami M, Raiesi O, Momen-Heravi M, Getso MI, Fakhrehi M, Mehri N, Yarahmadi M, Amiri S, Raissi V, Hashemi SJ. 2022. Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. Microb Pathog. May; 166:105520. DOI: 10.1016/j.micpath.2022.105520. Epub 2022 Apr 9. PMID: 35405278; PMCID: PMC8993493.
Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Holliday N, Killian SB. 2004 Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol. Feb; 42(2):718-21. DOI: 10.1128/JCM.42.2.718-721.2004. PMID: 14766842; PMCID: PMC344524.
Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P. 2004. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. J Antimicrob Chemother. Mar;53(3):526-9. DOI: 10.1093/jac/dkh106. Epub 2004 Feb 12. PMID: Journal: 14963064.
Gabaldón T, Carreté L. 2016. The birth of a deadly yeast: tracing the evolutionary emergence of virulence traits in Candida glabrata. FEMS Yeast Res 16(2) fov110; https://DOI:org/ 10.1093/femsyr/fov110.
Gabaldón T, Naranjo-Ortíz MA, Marcet-Houben M. 2016. Evolutionary genomics of yeast pathogens in the Saccharomycotina. FEMS Yeast Res 16(6) fow064; https://DOI:org/10.1093/femsyr/ fow064.
Jafarian H, Gharaghani M, Seyedian SS, Mahmoudabadi AZ. 2021. Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis. J Clin Lab Anal. Jul; 35(7):e23826. DOI: 10.1002/jcla.23826. Epub 2021 May 14. PMID: 33988259; PMCID: PMC8274993.
Jørgensen KJ, Gøtzsche PC, Dalbøge CS, Johansen HK. 2014. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev. Feb 24; 2014(2):CD004707. DOI: 10.1002/14651858.CD004707.pub3. PMID: 24563222; PMCID: PMC6457750.
Kalia N, Singh J, Sharma S, Kamboj S S, H Arora H, and Kaur M. 2015. Prevalence of Vulvovaginal Infections and Species Specific Distribution of Vulvovaginal Candidiasis in Married Women of North India. Int.J.Curr.Microbiol.App.Sci. 4(8): 253-266.
Kim KH, Kabir E, Jahan SA. 2018. Airborne bioaerosols and their impact on human health. J Environ Sci (China). 2018 May; 67:23-35. DOI: 10.1016/j.jes.2017.08.027. Epub 2017 Sep 20. PMID: 29778157; PMCID: PMC7128579.
Kumar P, Kausar, MA, Singh, AB. et al. 2021. Biological contaminants in the indoor air environment and their impacts on human health. Air Qual Atmos Health 14, 1723–1736. https://DOI:org/10.1007/s11869-021-00978-z.
Lone M S, Bashir G, Bali N, Sajad S, Aejaz S, Bashir H, Ahmad J. 2014. Oral Candida colonization and infection in cancer patients and their antifungal susceptibility in a tertiary care hospital. May International Journal of Advanced Research 2(5):541-550
Maheronnaghsh M, Fatahinia M, Dehghan P, Teimoori A. 2020. Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran. Adv Biomed Res. 30; 9:50. DOI: 10.4103/abr.abr_214_19. PMID: 33457333; PMCID: PMC7792871.
Martins N, Ferreira IC, Barros L, Silva S, Henriques M. 2014. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia. Jun; 177(5-6):223-40. DOI: 10.1007/s11046-014-9749-1. Epub 2014 May 1. PMID: 24789109.
Matare T, Nziramasanga P, Gwanzura L, Robertson V.2017. Experimental Germ Tube Induction in Candida albicans: An Evaluation of the Effect of Sodium Bicarbonate on Morphogenesis and Comparison with Pooled Human Serum. Biomed Res Int. ;2017:1976273. DOI: 10.1155/2017/1976273. Epub 5. PMID: 28656137; PMCID: PMC5474540.
Minati MH, AmeenMK M. 2020. Fungal Diversity of Winter Wheat Parts, Seed and Field Soil in Iraq, Basra Province. 2nd International Scientific Conference of Al-Ayen University (ISCAU-2020) IOP Publishing. IOP Conf. Series: Materials Science and Engineering 928 (2020) 062004 IOP Publishing DOI:10.1088/1757-899X/928/6/062004
Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. 2006. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi.;47(3):225-9. DOI: 10.3314/jjmm.47.225. PMID: 16940958.
Mirhendi H, Makimura K, Zomorodian K, Maeda N, Ohshima T, Yamaguchi H. 2005. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. Jpn J Infect Dis. ; 58(4):235-7. PMID: 16116258.
Mishra M, Agrawal S, Raut S, Kurhade AM, Powar RM. 2014. Profile of yeasts isolated from urinary tracts of catheterized patients. J Clin Diagn Res. Feb; 8(2):44-6. DOI: 10.7860/JCDR/2014/6614.4003. Epub Feb 3. PMID: 24701478; PMCID: PMC3972594.
Moldoveanu AM. 2015. Biological Contamination of Air in Indoor Spaces. Current Air Quality issues 489-514. https://DOI:org/10. 5772/59727
Montazeri A, Zandi H, Teymouri F. et al. 2020. Microbiological analysis of bacterial and fungal bioaerosols from burn hospital of Yazd (Iran) in 2019. J Environ Health Sci Engineer 18, 1121–1130. https://DOI:org/10.1007/s40201-020-00531-7.
Moran G P, Coleman D C, Sullivan D J. 2012. Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int. J. Microbiol. Article ID 205921 | https://DOI:org/10.1155/2012/205921
Nageen Y, Asemoloye MD, Põlme S, Wang X, Xu S, Ramteke PW, Pecoraro L. 2021. Analysis of culturable airborne fungi in outdoor environments in Tianjin, China. BMC Microbiol. 2; 21(1):134. DOI: 10.1186/s12866-021-02205-2. PMID: 33932997; PMCID: PMC8088404.
Obeed F K, Al-Saad L A, Alrubayae I M N.2022. The Prevalence of Hospital Acquired Fungal Infections in Some Hospitals of Basrah Province. Health Education and Health Promotion; 10(1):193-200
Oliveira LSS, Pinto LM, de Medeiros MAP, Toffaletti DL, Tenor JL, Barros TF, Neves RP, Neto RGL, Milan EP, Padovan ACB, Rocha WPDS, Perfect JR, Chaves GM. 2021. Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal Susceptibility. Front Cell Infect Microbiol. Jul 1;11:642658. DOI: 10.3389/fcimb.2021.642658. PMID: 34277464; PMCID: PMC8281300.
Papon N, Courdavault V, Clastre M, Bennett RJ. 2013. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog 9(9) e1003550; https://DOI:org/ 10.1371/journal.ppat.1003550.
Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG. 1994. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. J Clin Microbiol 32:1650–1653. DOI: 10.1128/JCM.32.7.1650-1653.1994.
Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. 2019. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. Open Forum Infect Dis. Mar 15; 6(Suppl 1):S79-S94. DOI: 10.1093/ofid/ofy358. PMID: 30895218; PMCID: PMC6419901.
Prasad P, Tippana M. 2023. Morphogenic plasticity: the pathogenic attribute of Candida albicans. Current Genetics: 1–13. DOI: 10.1007/s00294-023-01263-5.
Rayens E, Norris KA. 2022. Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018. Open Forum Infect Dis.10; 9(1):ofab593. DOI: 10.1093/ofid/ofab593. PMID: 35036461; PMCID: PMC8754384.
Reda NM, Hassan RM, Salem ST, Yousef RHA. 2023. Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr. Infection. Apr; 51 (2):389-395. DOI: 10.1007/s15010-022-01888-7. Epub 2022 Aug 26. PMID: 36018493; PMCID: PMC10042939.
Roshan SK, Sedighe NB et al. 2019. Study on the relationship between the concentration and type of fungal bio-aerosols at indoor and outdoor air in the Children’s Medical Center, Tehran, Iran. Environ Monit Assess 191(2):48 DOI: 10.1007/s10661-018-7183-4.
Rostami N, Alidadi H, Zarrinfar H, and Salehi P.2016. Assessment of indoor and outdoor airborne fungi in an Educational, Research and Treatment Center. Italian Journal of Medicine, 11(1), 52–56. https://DOI:org/10.4081/itjm.2016.663
Sambrook J, Fritsch E R, and Maniatis T. 1989. Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. Jan; 62(Pt 1):10-24. DOI: 10.1099/jmm.0.045054-0. Epub 2012 Nov 22. PMID: 23180477.
Scharmann, U, Kirchhoff, L, Chapot, VLS, et al. 2020. Comparison of four commercially available chromogenic media to identify Candida albicans and other medically relevant Candida species. Mycoses; 63: 823– 831. https://DOI:org/10.1111/myc.13119
Sharma SP, Aggarwal A. 2013. Nosocomial Candida infection in a rural tertiary care hospital. J Clin Diagn Res. Feb; 7(2):405-6. DOI: 10.7860/JCDR/2013/4574.2759. Epub 2013 Feb 1. PMID: 23544180; PMCID: PMC3592327.
Shokohi T, Hashemi Soteh MB, Saltanat Pouri Z, Hedayati MT, Mayahi S. 2010. Identification of Candida species using PCR-RFLP in cancer patients in Iran. Indian J Med Microbiol. Apr-Jun;28(2):147-51. DOI: 10.4103/0255-0857.62493. PMID: 20404462.
Shokohi, T.; Bandalizadeh, Z.; Hedayati, M. T. and Mayahi, S. (2011). In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol. 4(Supplement 1):S19-S26.
Tang HJ, Liu WL, Lin HL, Lai CC. 2014. Epidemiology and prognostic factors of candidemia in cancer patients. PLoS One. Jun 5; 9(6):e99103. DOI: 10.1371/journal.pone.0099103. PMID: 24901336; PMCID: PMC4047064.
Tendolkar U, Tainwala S, Jog S, Mathur M. 2003. Use of a new medium - tobacco agar, for pigment production of Cryptococcus neoformans. Indian J Med Microbiol. Oct-Dec; 21(4):277-9. PMID: 17643044.
United States Environmental Protection agency (EPA). 2020. Chloramine in Drinking Water, Drinking water requirements for states and public watewr Systems. Availableon: https://www.epa.gov/dwreginfo/chloramines-drinking-water Accessed on: 9 June 2020.
Van Leuken JPG, Swart AN, Havelaar AH, Van Pul A, Van der Hoek W, Heederik D. 2016. Atmospheric dispersion modelling of bioaerosols that are pathogenic to humans and livestock—a review to inform risk assessment studies. Microb. Risk Anal.; 1:19–39. https://DOI:org/10.1016/j.mran.2015.07.002.
Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, Deku JG, Kasu ES, Mensah P, Agede CY, Dodoo C, Asiamah EA, Tampuori J, Korbuvi J, Opintan JA.2020. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth.6; 20 (1):266. DOI: 10.1186/s12884-020-02963-3. PMID: 32375724; PMCID: PMC7201979.
Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. Mar;10 Suppl 1:48-66. DOI: 10.1111/j.1470-9465.2004.00839.x. PMID: 14748802.
Xia R, Wang D. 2019. Risk factors of invasive candidiasis in critical cancer patients after various gastrointestinal surgeries: A 4-year retrospective study. Medicine (Baltimore). Nov;98(44):e17704. DOI: 10.1097/MD.0000000000017704. PMID: 31689800; PMCID: PMC6946494.
Xiao M, Chen SC, Kong F, Xu XL, Yan L, Kong HS, Fan X, Hou X, Cheng JW, Zhou ML, Li Y, Yu SY, Huang JJ, Zhang G, Yang Y, Zhang JJ, Duan SM, Kang W, Wang H, Xu YC. 2020. Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study. J Infect Dis. Mar 16; 221(Suppl 2):S139-S147. DOI: 10.1093/infdis/jiz573. PMID: 32176789.
Yesudhason BL, Mohanram K. 2015. Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India. J Clin Diagn Res. Jul; 9(7):DC14-6. DOI: 10.7860/JCDR/2015/13460.6208.